Zobrazeno 1 - 10
of 158
pro vyhledávání: '"Marc I, Chimowitz"'
Autor:
Yannan Yu, Wei-Hai Xu, Arindam Rano Chatterjee, Todd LeMatty, Meng Yao, Ming-Li Li, Truman Brown, Maria Vittoria Spampinato, Renee Martin, Marc I. Chimowitz, Colin Derdeyn, Tanya N. Turan
Publikováno v:
Clinical and Translational Neuroscience, Vol 6, Iss 3, p 16 (2022)
Background and Objective: Intracranial atherosclerosis (ICAS) is one of the most common causes of stroke worldwide. High-resolution Vessel Wall MR imaging (VW-MR) is commonly used to study ICAS, but in order to accelerate advances in the field of VW-
Externí odkaz:
https://doaj.org/article/3dbcf03a0ac84b63bfe73adb3045d99e
Autor:
Chengbei Hou, Jing Lan, Yinan Lin, Haiqing Song, Yuan Wang, Wenbo Zhao, Sijie Li, Ran Meng, Junwei Hao, Yuchuan Ding, Marc I Chimowitz, Marc Fisher, David C Hess, David S Liebeskind, Derek J Hausenloy, Jie Huang, Zhenguang Li, Xiujie Han, Jinbo Yang, Jin Zhou, Peimin Chen, Xinchen Zhu, Peilin Hu, Hongbo Pang, Wenwu Chen, Huisheng Chen, Guozhong Li, Dingbo Tao, Wei Yue, Zongen Gao, Xunming Ji
Publikováno v:
The Lancet Neurology. 21:1089-1098
Publikováno v:
Brain Circulation, Vol 2, Iss 2, Pp 67-71 (2016)
Intracranial atherosclerotic arterial stenosis (ICAS) is one of the most common causes of stroke worldwide and is associated with particularly a high risk of recurrent stroke. Although aggressive medical management, consisting of dual antiplatelet th
Externí odkaz:
https://doaj.org/article/1484225fc7644d92bdaaedcee7f047a8
Autor:
Tanya N. Turan, Osama O. Zaidat, Gary S. Gronseth, Marc I. Chimowitz, Antonio Culebras, Anthony J. Furlan, Larry B. Goldstein, Nestor R. Gonzalez, Julius G. Latorre, Steven R. Messé, Thanh N. Nguyen, Rajbeer S. Sangha, Michael J. Schneck, Aneesh B. Singhal, Lawrence R. Wechsler, Alejandro A. Rabinstein, Mary Dolan O'Brien, Heather Silsbee, Jeffrey J. Fletcher
Publikováno v:
Neurology
Background and ObjectivesTo review treatments for reducing the risk of recurrent stroke or death in patients with symptomatic intracranial atherosclerotic arterial stenosis (sICAS).MethodsThe development of this practice advisory followed the process
Publikováno v:
The Lancet. Neurology. 21(4)
Intracranial atherosclerotic stenosis (ICAS) is one of the most frequent causes of stroke worldwide and confers one of the greatest risks of recurrent stroke compared with other causes of stroke. Asymptomatic ICAS is increasingly recognised as a risk
Autor:
Rechelle Paranal, Joseph Gough, Heather Shaw Bonilha, Edward L. Krug, Jacqueline F. McGinty, Kathleen T. Brady, Jillian Harvey, Kathie L. Hermayer, Marc I. Chimowitz, Madison Hyer, Gerard A. Silvestri, Perry V. Halushka, Bonnie Martin-Harris, Joann F. Sullivan, Barbara J Edlund, Mary Mauldin, Dayan Ranwala
Publikováno v:
Journal of Clinical and Translational Science
Background:There is discontent and turnover among faculty at US academic health centers because of the challenges in balancing clinical, research, teaching, and work–life responsibilities in the current healthcare environment. One potential strateg
Autor:
Seemant Chaturvedi, Gary S. Roubin, Kevin M. Barrett, Marc I Chimowitz, Thomas G. Brott, Bart M. Demaerschalk, George Howard, James F. Meschia, Jenifer H. Voeks, Tanya N Turan, Claudia S. Moy, Virginia J. Howard, Jeffrey Goldstein, Brajesh K. Lal, Ronald M. Lazar, Wesley S. Moore, Robert D. Brown, Philip Teal
Publikováno v:
Stroke. 52
Background: Data from the CDC show that approximately one-quarter of adults have elevated triglyceride (TG) levels. Recent trials have demonstrated that pharmacologic treatment of high TG levels, in patients already on statin therapy, reduces the rat
Autor:
Sebastian Koch, Edward Feldmann, David S Liebeskind, Lauren Ostergren, MyRIAD Investigators, Rajbeer S Sangha, Nizam Azhar, Tatjana Rundek, Marc I. Chimowitz, Iszet Campo-Bustillo, Shyam Prabhakaran, Jose G. Romano
Publikováno v:
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, vol 29, iss 10
J Stroke Cerebrovasc Dis
J Stroke Cerebrovasc Dis
RATIONALE: Intracranial atherosclerotic disease (ICAD) is the most common cause of ischemic stroke with the highest rate of recurrence, despite aggressive medical management. Diverse mechanisms may be responsible for ICAD-related cerebral ischemia, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e31a428905e0c62d3e4d6c0ba545c4a
https://escholarship.org/uc/item/1g78913w
https://escholarship.org/uc/item/1g78913w
Autor:
Thomas G. Brott, Brajesh K. Lal, Jenifer H. Voeks, Todd LeMatty, Marc I. Chimowitz, Seemant Chaturvedi, Maria F. Lopes-Virella, Donald Heck, George Howard, Ana Roldan, William Haley, Michael R. Jones, Tanya N. Turan, James F. Meschia
Publikováno v:
Stroke
Background and Purpose: The CREST2 trial (Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis) is comparing intensive medical management (IMM) alone to IMM plus revascularization with carotid endarterectomy or transfemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a5c0b68bf82fdcbc94275a2fac4c819
https://europepmc.org/articles/PMC7530035/
https://europepmc.org/articles/PMC7530035/
Autor:
Sothear Luke, Ana Roldan, Todd LeMatty, Jon Foley, Linda Breathitt, James F. Meschia, Tanya N. Turan, Marc I. Chimowitz, Thomas G. Brott, Robin Eiland
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases
Introduction The COVID-19 pandemic has presented challenges to managing vascular risk factors with in-person follow-up of patients with asymptomatic carotid stenosis enrolled in the CREST2 trial. CREST2 is comparing intensive medical management alone